SCHEMBL24737023

SCHEMBL24737023

SN[C@H]1CC[C@H](N(CC2CC2)CC2CC2)CC1

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 1/20 0.30
▸ SLC6A4 P31645 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23943786 0.74 GAA (0.31) —
SCHEMBL24774770 0.74 — —
SCHEMBL2707771 0.72 KMT2A (0.37) SLC6A2SLC6A4
SCHEMBL2707770 0.72 KMT2A (0.37) SLC6A2SLC6A4
SCHEMBL24080142 0.71 LTA4H (0.36) SLC6A2SLC6A4
SCHEMBL12448946 0.70 — —
SCHEMBL12938308 0.69 — —
SCHEMBL12449085 0.69 LTA4H (0.38) SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL2697435 0.68 ALOX5 (0.32) —
SCHEMBL11638870 0.67 SLC6A2 (0.30) SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022256489-A1 METHODS OF TREATING B-CELL MALIGNANCY USING BCL-2 INHIBITOR BEIGENE, LTD. (KY) 2022-12-08 — — WO disclosed
Send feedback